Insulet Corporation to Present at Upcoming Investor Conference
Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced that
management will present at the William Blair & Co. 37th Annual Growth Stock Conference in Chicago, Illinois on Tuesday, June
13, 2017 at 12:50 p.m. (Central Time).
To listen to a live audio webcast of the presentation, please visit http://investors.insulet.com. A replay of the webcast will also be available following the event.
About Insulet Corporation:
Insulet Corporation (NASDAQ: PODD) is an innovative medical device company dedicated to making the lives of people with diabetes
easier. Through its Omnipod Insulin Management System, Insulet seeks to expand the use of insulin pump therapy among people with
insulin-dependent diabetes. The Omnipod is a revolutionary and easy-to-use tubeless insulin pump that provides up to three days of
non-stop insulin delivery, without the need to see or handle a needle. Insulet's Delivery Systems business also partners with
global pharmaceutical and biotechnology companies to adapt the Omnipod technology platform for the delivery of subcutaneous drugs
across multiple therapeutic areas. Founded in 2000, Insulet Corporation is based in Billerica, Massachusetts. For more information,
please visit: http://www.myomnipod.com.
Insulet Corporation
Deborah R. Gordon, 978-600-7717
Vice President, Investor Relations and Corporate Communications
dgordon@insulet.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20170605005662/en/